Brian Paegel receives NIH award for drug discovery tech development

The National Institutes of Health has granted $2 million to researchers in UCI’s School of Pharmacy & Pharmaceutical Sciences. The new Maximizing Investigators’ Research Award will fund drug discovery technology development in the laboratory of Brian Paegel, UCI professor of pharmaceutical sciences.

“The NIH has generously supported my laboratory over the years in reaction miniaturization and automated, high-speed chemical analysis,” Paegel said. “The MIRA will allow us to explore high-risk approaches that circumvent the canonical rules of druggability. Instead of targeting mature proteins in the cell, the modus operandi of drug discovery, we are engineering cutting-edge chemical and analytical tools to find molecules that control the process of protein synthesis itself.”

Paegel’s collaborators include RNA chemical biologist Robert Spitale, another UCI professor of pharmaceutical sciences; and ribosome structural biologist Jamie Cate, UC Berkeley professor of chemistry. The highly interdisciplinary project – involving instrumentation engineering, molecular and cellular biology, polymer chemistry, chemical synthesis and informatics – is the latest example of intensifying convergent science initiatives at UCI.

Learn more about research in the Paegel Lab.

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Subscribe To Our Newsletter

Get updates From the UCI School of Pharmacy and Pharmaceutical Sciences

More To Explore


Hispanic Heritage Month With Emily Castro

Emily Castro, a fourth-year, first-generation student in the PhD in pharmacological sciences program, shares advice to others forging new paths.